Prostate Stimulation for Sexual Dysfunction
1 other identifier
interventional
15
1 country
1
Brief Summary
The purpose of this study is to use a device to stimulate the prostate with a goal of helping improve symptoms in men with sexual dysfunction.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 18, 2022
CompletedFirst Posted
Study publicly available on registry
July 21, 2022
CompletedStudy Start
First participant enrolled
April 18, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 1, 2026
June 3, 2025
May 1, 2025
2.1 years
July 18, 2022
May 28, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
change in modified International Index of Erectile Dysfunction score
score 0 to 30 with higher score meaning better erectile function
baseline and up to 1 month post-baseline
Study Arms (1)
Prostate stimulation device arm
EXPERIMENTALParticipants will be asked to use our prostate stimulation device.
Interventions
Prostate stimulation device for sexual dysfunction
Eligibility Criteria
You may qualify if:
- Males \>18 years of age suffering from sexual dysfunction
You may not qualify if:
- Individuals who have had a prostatectomy - removal of prostate
- Inability to operate the device for any reason
- Females
- Males \<18 years of age
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Stanford Healthcare, Stanford Hospital
Stanford, California, 94304, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Michael Eisenberg, M.D.
Stanford University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Study Principal Investigator
Study Record Dates
First Submitted
July 18, 2022
First Posted
July 21, 2022
Study Start
April 18, 2024
Primary Completion (Estimated)
June 1, 2026
Study Completion (Estimated)
June 1, 2026
Last Updated
June 3, 2025
Record last verified: 2025-05